In an abrupt turnaround from its previous stance, Merck & Co. spokesman Kent Jarrell told the Associated Press today that it might consider settling some of its lawsuits. However, the company continues to insist it won’t enter into any type of global settlement. Perhaps as more bad facts surface surrounding Vioxx, they may change their opinion once again.